Simona La Seta Catamancio

Susceptibility to PNU-140690 (Tipranavir) of Human Immunodeficiency Virus Type 1 Isolates Derived from Patients with Multidrug Resistance to Other Protease Inhibitors

Stefano Rusconi, Simona La Seta Catamancio, Paola Citterio et al. · Antimicrobial Agents and Chemotherapy · 2000 · 91 citations · Full text

Combination of CCR5 and CXCR4 Inhibitors in Therapy of Human Immunodeficiency Virus Type 1 Infection: In Vitro Studies of Mixed Virus Infections

Stefano Rusconi, Simona La Seta Catamancio, Paola Citterio et al. · Journal of Virology · 2000 · 27 citations · Full text

Loss of Lamivudine Resistance in a Zidovudine and Lamivudine Dual-Resistant HIV-1 Isolate after Discontinuation of <i>In Vitro</i> Lamivudine Drug Pressure

Stefano Rusconi, Maria Pia De Pasquale, Laura Milazzo et al. · Antiviral Therapy · 1998 · 19 citations

In Vitro Evolution of the Human Immunodeficiency Virus Type 1 Gag-Protease Region and Maintenance of Reverse Transcriptase Resistance following Prolonged Drug Exposure

Simona La Seta Catamancio, Maria Pia De Pasquale, Paola Citterio et al. · Journal of Clinical Microbiology · 2001 · 13 citations · Full text

A genotypic analysis of patients receiving Zidovudine with either Lamivudine, Didanosine or Zalcitabine dual therapy using the LiPA point mutation assay to detect genotypic variation at codons 41, 69, 70, 74, 184 and 215

Stefano Rusconi, Simona La Seta Catamancio, Francis Sheridan et al. · Journal of Clinical Virology · 2000 · 12 citations

Lipa Point Mutation, Genetic Epidemiology, Pharmacology +8